Stock Events

Stock Events

Calidi Biotherapeutics (CLDI) Q4 2024 Earnings

12NovConfirmed

Q2 2024

Q3 2024

Q4 2024

-2.75

-2.05

-1.35

-0.65

Details

Expected EPS

-0.8555

Actual EPS

-0.65

Surprise EPS

0.21

Surprise Percent

+24.02%

Description

Calidi Biotherapeutics (CLDI) has reported earnings of -0.65 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.